- Home
- LYEL vs RILYP Comparison
LYEL vs RILYP Comparison
Compare LYEL & RILYP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYEL
- RILYP
- Stock Information
- Founded
- LYEL 2018
- RILYP N/A
- Country
- LYEL United States
- RILYP United States
- Employees
- LYEL N/A
- RILYP 2383
- Industry
- LYEL Biotechnology: Pharmaceutical Preparations
- RILYP Investment Managers
- Sector
- LYEL Health Care
- RILYP Finance
- Exchange
- LYEL Nasdaq
- RILYP Nasdaq
- Market Cap
- LYEL 263.9M
- RILYP N/A
- IPO Year
- LYEL 2021
- RILYP N/A
- Fundamental
- Price
- LYEL $0.65
- RILYP $6.34
- Analyst Decision
- LYEL Sell
- RILYP
- Analyst Count
- LYEL 2
- RILYP 0
- Target Price
- LYEL $1.00
- RILYP N/A
- AVG Volume (30 Days)
- LYEL 1.3M
- RILYP N/A
- Earning Date
- LYEL 02-26-2025
- RILYP N/A
- Dividend Yield
- LYEL N/A
- RILYP N/A
- EPS Growth
- LYEL N/A
- RILYP N/A
- EPS
- LYEL N/A
- RILYP N/A
- Revenue
- LYEL $63,000.00
- RILYP N/A
- Revenue This Year
- LYEL N/A
- RILYP N/A
- Revenue Next Year
- LYEL N/A
- RILYP N/A
- P/E Ratio
- LYEL N/A
- RILYP N/A
- Revenue Growth
- LYEL N/A
- RILYP N/A
- 52 Week Low
- LYEL $0.58
- RILYP N/A
- 52 Week High
- LYEL $3.26
- RILYP N/A
- Technical
- Relative Strength Index (RSI)
- LYEL 34.74
- RILYP 39.93
- Support Level
- LYEL $0.60
- RILYP $5.65
- Resistance Level
- LYEL $0.71
- RILYP $6.85
- Average True Range (ATR)
- LYEL 0.06
- RILYP 0.32
- MACD
- LYEL 0.01
- RILYP -0.02
- Stochastic Oscillator
- LYEL 23.51
- RILYP 44.52
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About RILYP B. Riley Financial Inc.
B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.